Renal Injury during Long-Term Crizotinib Therapy

Renal Injury during Long-Term Crizotinib Therapy

Crizotinib is highly effective against anaplastic lymphoma kinase-positive and c-ros oncogen1-positive non-small cell lung cancer. Renal dysfunction is associated with crizotinib therapy but the mechanism is unknown. Here, we report a case of anaplastic lymphoma kinase positive non-small cell lung c...

Full description

Bibliographic Details
Main Authors: Taro Yasuma, Tetsu Kobayashi, Corina N. D’Alessandro-Gabazza, Hajime Fujimoto, Kentaro Ito, Yoichi Nishii, Kota Nishihama, Prince Baffour Tonto, Atsuro Takeshita, Masaaki Toda, Esteban C. Gabazza, Osamu Taguchi, Shigenori Yonemura, Osamu Hataji
Format: Article
Language:English
Published: MDPI AG 2018-09-01
Series:International Journal of Molecular Sciences
Subjects:
lung cancer
renal injury
fibrosis
crizotinib
anaplastic lymphoma kinase
cystic formation
Online Access:http://www.mdpi.com/1422-0067/19/10/2902

Internet

http://www.mdpi.com/1422-0067/19/10/2902

Similar Items